Inspite of being manufactured for less than $5 per month, copyright carries a retail selling price that is challenging to justify. The significant gap between production expenses and pricing raises crucial questions about the pharmaceutical market's pricing techniques.California biotech behemoth Amgen ditched plans for an experimental weight loss t